Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 18
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
6/17/2008
 
First Published:
5/28/2004
1.
Phase III Randomized Study of Cisplatin and Radiotherapy With or Without Hyperthermia in Patients With Locally Advanced Carcinoma of the Cervix
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
NCI
DUMC-4516-04-2R1ER
DUMC-G030263, DUMC-4516031R0, NCT00085631
Last Modified:
10/10/2008
 
First Published:
11/25/2005
2.
Phase III Randomized Study of Cisplatin and Radiotherapy With Versus Without Tirapazamine in Patients With Stage IB, IIA, IIB, IIIB, or IVA Carcinoma of the Cervix
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
NCI
GOG-0219
GOG-0219, CAN-NCIC-GOG-0219, NCT00262821
3.
Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
UCI 03-33
NCT00257816
4.
Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
05-0702
CA225243, NCT00292955
Last Modified:
10/8/2008
 
First Published:
8/18/2006
5.
Phase II Study of Bevacizumab, Definitive Radiotherapy, and Cisplatin in Patients With Previously Untreated Locally Advanced Cervical Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
Not specified
NCI
RTOG-0417
RTOG-0417, NCT00369122
Last Modified:
5/22/2008
 
First Published:
5/4/2007
6.
Phase II Pilot Study of Irradiated Allogeneic Related Donor Lymphocyte Infusion in Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Active
Any age
NCI
CINJ-3330
NCT00161187
7.
Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
AVF3963s
NCT00600210
Last Modified:
9/3/2008
 
First Published:
1/26/2003
8.
Phase I Study of Pelvic or Pelvic Radiotherapy, Cisplatin, and Topotecan in Patients With Locally Advanced Cervical Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
Not specified
NCI
GOG-9913
NCT00054444, GOG-9913
Last Modified:
9/23/2008
 
First Published:
2/18/2005
9.
Phase I Study of Cetuximab in Combination With Cisplatin, External Beam Radiotherapy, and Brachytherapy in Patients With Stage IB-IVA Cervical Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
NCI
GOG-9918
GOG-9918, NCT00104910
10.
A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
Other
05C.255
NCT00329589
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute